Amygdala enlargement in bipolar disorder and hippocampal reduction in schizophrenia: an MRI study demonstrating neuroanatomic specificity.

PubWeight™: 1.53‹?› | Rank: Top 4%

🔗 View Article (PMID 9672058)

Published in Arch Gen Psychiatry on July 01, 1998

Authors

L L Altshuler, G Bartzokis, T Grieder, J Curran, J Mintz

Associated clinical trials:

The Functional Anatomy of Personality Trait Knowledge: An fMRI Study | NCT00095407

Clozapine for Treatment-Resistant Mania | NCT00029458

Articles citing this

A review of MRI findings in schizophrenia. Schizophr Res (2001) 8.95

A neural model of voluntary and automatic emotion regulation: implications for understanding the pathophysiology and neurodevelopment of bipolar disorder. Mol Psychiatry (2008) 5.06

Bipolar and major depressive disorder: neuroimaging the developmental-degenerative divide. Neurosci Biobehav Rev (2009) 2.44

Evidence for deficient modulation of amygdala response by prefrontal cortex in bipolar mania. Psychiatry Res (2007) 1.93

Stress reduction correlates with structural changes in the amygdala. Soc Cogn Affect Neurosci (2009) 1.86

Pediatric bipolar disorder: validity, phenomenology, and recommendations for diagnosis. Bipolar Disord (2008) 1.59

Dysregulation of the behavioral approach system (BAS) in bipolar spectrum disorders: review of theory and evidence. Clin Psychol Rev (2008) 1.58

An fMRI study of the neural correlates of incidental versus directed emotion processing in pediatric bipolar disorder. J Am Acad Child Adolesc Psychiatry (2009) 1.42

Stress-induced structural remodeling in hippocampus: prevention by lithium treatment. Proc Natl Acad Sci U S A (2004) 1.37

A critical appraisal of neuroimaging studies of bipolar disorder: toward a new conceptualization of underlying neural circuitry and a road map for future research. Am J Psychiatry (2014) 1.34

Increased volume of the amygdala and hippocampus in bipolar patients treated with lithium. Neuroreport (2008) 1.24

Identifying functional neuroimaging biomarkers of bipolar disorder: toward DSM-V. Schizophr Bull (2007) 1.24

Reduced gray matter volume in ventral prefrontal cortex but not amygdala in bipolar disorder: significant effects of gender and trait anxiety. Psychiatry Res (2008) 1.20

The psychopathology and treatment of bipolar disorder. Annu Rev Clin Psychol (2006) 1.18

Cognitive and neurological impairment in mood disorders. Psychiatr Clin North Am (2004) 1.17

Amygdala volume in depressed patients with bipolar disorder assessed using high resolution 3T MRI: the impact of medication. Neuroimage (2009) 1.16

Volume deficits of subcortical nuclei in mood disorders A postmortem study. Eur Arch Psychiatry Clin Neurosci (2005) 1.10

Frontolimbic structural changes in borderline personality disorder. J Psychiatr Res (2007) 1.05

Amygdalae morphometry in late-life depression. Int J Geriatr Psychiatry (2009) 1.01

A Ventral Prefrontal-Amygdala Neural System in Bipolar Disorder: A View from Neuroimaging Research. Acta Neuropsychiatr (2009) 1.01

Parvalbumin neurons in the entorhinal cortex of subjects diagnosed with bipolar disorder or schizophrenia. Biol Psychiatry (2006) 0.98

Functional neuroanatomy of bipolar disorder: structure, function, and connectivity in an amygdala-anterior paralimbic neural system. Bipolar Disord (2012) 0.93

Age-dependent reduction of amygdala volume in bipolar disorder. Psychiatry Res (2008) 0.93

Hippocampus and amygdala morphology in adults with attention-deficit hyperactivity disorder. J Psychiatry Neurosci (2008) 0.88

Pharmacotherapy impacts functional connectivity among affective circuits during response inhibition in pediatric mania. Behav Brain Res (2011) 0.88

Amygdalar, hippocampal, and thalamic volumes in youth at high risk for development of bipolar disorder. Psychiatry Res (2011) 0.88

Brain gray matter phenotypes across the psychosis dimension. Psychiatry Res (2012) 0.87

Overlapping and distinct gray and white matter abnormalities in schizophrenia and bipolar I disorder. Bipolar Disord (2013) 0.87

Neuroprotective effects of antidepressant and mood stabilizing drugs. J Psychiatry Neurosci (2002) 0.86

Affect regulation: a systems neuroscience perspective. Neuropsychiatr Dis Treat (2005) 0.84

Neuron somal size is decreased in the lateral amygdalar nucleus of subjects with bipolar disorder. J Psychiatry Neurosci (2007) 0.83

Magnetic resonance spectroscopy in the evaluation of treatment efficacy in unipolar major depressive disorder: a review of the literature. Funct Neurol (2012) 0.83

Morphometry of the hippocampus and amygdala in bipolar disorder and schizophrenia. Bipolar Disord (2010) 0.83

Gray and white matter brain volumes in older adults with bipolar disorder. Int J Geriatr Psychiatry (2009) 0.82

Amygdala volume and psychopathology in childhood complex partial seizures. Epilepsy Behav (2008) 0.82

Temporal lobe volume in bipolar disorder: relationship with diagnosis and antipsychotic medication use. J Affect Disord (2008) 0.81

Mood-state effects on amygdala volume in bipolar disorder. J Affect Disord (2012) 0.80

Genomic structural variants are linked with intellectual disability. J Neural Transm (Vienna) (2015) 0.79

Three-dimensional mapping of hippocampal and amygdalar structure in euthymic adults with bipolar disorder not treated with lithium. Psychiatry Res (2012) 0.79

Subcortical volumetric correlates of anxiety in familial pediatric bipolar disorder: a preliminary investigation. Psychiatry Res (2009) 0.78

Lithium's role in neural plasticity and its implications for mood disorders. Acta Psychiatr Scand (2013) 0.78

Differential abnormalities of functional connectivity of the amygdala and hippocampus in unipolar and bipolar affective disorders. J Affect Disord (2014) 0.77

An MRI study of amygdala in schizophrenia and psychotic bipolar disorder. Schizophr Res (2012) 0.77

The impact of limbic system morphology on facial emotion recognition in bipolar I disorder and healthy controls. Neuropsychiatr Dis Treat (2013) 0.76

Moods as ups and downs of the motivation pendulum: revisiting reinforcement sensitivity theory (RST) in bipolar disorder. Front Behav Neurosci (2014) 0.76

The gray matter volume of the amygdala is correlated with the perception of melodic intervals: a voxel-based morphometry study. PLoS One (2014) 0.76

Neuroplasticity in mood disorders. Dialogues Clin Neurosci (2004) 0.76

Evidence of altered DNA integrity in the brain regions of suicidal victims of Bipolar Depression. Indian J Psychiatry (2010) 0.76

Bipolar disorder affects behavior and social skills on the Internet. PLoS One (2013) 0.76

Developing therapeutics for schizophrenia and other psychotic disorders. NeuroRx (2005) 0.75

Atrophy of the Posterior Subiculum Is Associated with Memory Impairment, Tau- and Aβ Pathology in Non-demented Individuals. Front Aging Neurosci (2017) 0.75

Articles by these authors

Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the "right stuff"? Schizophr Bull (2000) 9.62

Disability income, cocaine use, and repeated hospitalization among schizophrenic cocaine abusers--a government-sponsored revolving door? N Engl J Med (1995) 4.77

Skills training versus psychosocial occupational therapy for persons with persistent schizophrenia. Am J Psychiatry (1998) 4.31

Informed consent: assessment of comprehension. Am J Psychiatry (1998) 3.74

Training and quality assurance with the Structured Clinical Interview for DSM-IV (SCID-I/P). Psychiatry Res (1998) 3.69

A highly recombinogenic system for the recovery of infectious Sendai paramyxovirus from cDNA: generation of a novel copy-back nondefective interfering virus. EMBO J (1995) 3.63

Genital ulcers in Kenya. Clinical and laboratory study. Br J Vener Dis (1981) 3.62

Paramyxovirus RNA synthesis and the requirement for hexamer genome length: the rule of six revisited. J Virol (1998) 3.60

Age-related changes in frontal and temporal lobe volumes in men: a magnetic resonance imaging study. Arch Gen Psychiatry (2001) 2.91

Tranylcypromine vs. lamotrigine in the treatment of refractory bipolar depression: a failed but clinically useful study. Acta Psychiatr Scand (2007) 2.89

Molecular cloning of natural paramyxovirus copy-back defective interfering RNAs and their expression from DNA. Virology (1992) 2.89

Complexes of Sendai virus NP-P and P-L proteins are required for defective interfering particle genome replication in vitro. J Virol (1992) 2.73

Editing of the Sendai virus P/C mRNA by G insertion occurs during mRNA synthesis via a virus-encoded activity. J Virol (1990) 2.50

Implications of therapist effects for the design and analysis of comparative studies of psychotherapies. J Consult Clin Psychol (1991) 2.49

Clinical outcome following neuroleptic discontinuation in patients with remitted recent-onset schizophrenia. Am J Psychiatry (2001) 2.47

The Stanley Foundation Bipolar Treatment Outcome Network. II. Demographics and illness characteristics of the first 261 patients. J Affect Disord (2001) 2.43

Meiotic pairing behavior of two free duplications of linkage group I in Caenorhabditis elegans. Mol Gen Genet (1984) 2.39

Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder. Am J Psychiatry (2001) 2.38

A stuttering model for paramyxovirus P mRNA editing. EMBO J (1990) 2.30

Pharmacologic management of psychiatric illness during pregnancy: dilemmas and guidelines. Am J Psychiatry (1996) 2.14

Relationship between white matter fractional anisotropy and other indices of cerebral health in normal aging: tract-based spatial statistics study of aging. Neuroimage (2006) 2.09

Developmental Processes in Schizophrenic Disorders: longitudinal studies of vulnerability and stress. Schizophr Bull (1992) 2.08

Primary angiitis of the central nervous system in children: 5 cases. J Rheumatol (2001) 2.08

The Sendai paramyxovirus accessory C proteins inhibit viral genome amplification in a promoter-specific fashion. J Virol (1996) 1.94

Funding Canada's health care system: a tax-based alternative to privatization. CMAJ (1998) 1.92

Does thyroid supplementation accelerate tricyclic antidepressant response? A review and meta-analysis of the literature. Am J Psychiatry (2001) 1.85

Sendai virus C proteins must interact directly with cellular components to interfere with interferon action. J Virol (2000) 1.69

Localized two-dimensional shift correlated MR spectroscopy of human brain. Magn Reson Med (2001) 1.67

Tetrameric coiled coil domain of Sendai virus phosphoprotein. Nat Struct Biol (2000) 1.65

The P gene of human parainfluenza virus type 1 encodes P and C proteins but not a cysteine-rich V protein. J Virol (1991) 1.64

Sendai virus Y proteins are initiated by a ribosomal shunt. Mol Cell Biol (1998) 1.63

The P gene of bovine parainfluenza virus 3 expresses all three reading frames from a single mRNA editing site. EMBO J (1991) 1.62

Absence of evidence for bornavirus infection in schizophrenia, bipolar disorder and major depressive disorder. Mol Psychiatry (2012) 1.59

Inhibition of Sendai virus genome replication due to promoter-increased selectivity: a possible role for the accessory C proteins. J Virol (1997) 1.59

Mood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline. Br J Psychiatry (2006) 1.58

Family factors and the course of bipolar affective disorder. Arch Gen Psychiatry (1988) 1.57

Molecular characterization of human immunodeficiency virus from Zaire: nucleotide sequence analysis identifies conserved and variable domains in the envelope gene. Gene (1987) 1.55

Patients' perceptions of family emotional climate and outcome in schizophrenia. Br J Psychiatry (1993) 1.55

Molecular characteristics of non-small cell lung cancer. Proc Natl Acad Sci U S A (2001) 1.53

Novel antipsychotics: comparison of weight gain liabilities. J Clin Psychiatry (1999) 1.53

An MRI study of temporal lobe structures in men with bipolar disorder or schizophrenia. Biol Psychiatry (2000) 1.53

The antiviral adaptor proteins Cardif and Trif are processed and inactivated by caspases. Cell Death Differ (2008) 1.51

Differential efficacy of olanzapine for deficit and nondeficit negative symptoms in schizophrenia. Am J Psychiatry (2000) 1.49

Backward masking in schizophrenia and mania. II. Specifying the visual channels. Arch Gen Psychiatry (1994) 1.44

Plasma levels of fluphenazine in patients receiving fluphenazine decanoate. Relationship to clinical response. Br J Psychiatry (1991) 1.42

In vivo evaluation of brain iron in Alzheimer disease using magnetic resonance imaging. Arch Gen Psychiatry (2000) 1.41

Backward masking in schizophrenia and mania. I. Specifying a mechanism. Arch Gen Psychiatry (1994) 1.40

The temporal relationship between depressive and psychotic symptoms in recent-onset schizophrenia. Am J Psychiatry (1990) 1.40

The relationship between antimanic agent for treatment of classic or dysphoric mania and length of hospital stay. J Clin Psychiatry (1996) 1.40

Processing speed is correlated with cerebral health markers in the frontal lobes as quantified by neuroimaging. Neuroimage (2009) 1.39

Recurrent mood shifts of premenstrual dysphoric disorder can be mistaken for rapid-cycling bipolar II disorder. J Clin Psychiatry (1998) 1.39

Does risperidone improve verbal working memory in treatment-resistant schizophrenia? Am J Psychiatry (1997) 1.39

Statistical guidelines for the Archives of PM&R. New Hampshire-Dartmouth Psychiatric Research Center. Arch Phys Med Rehabil (1995) 1.38

Field dependent transverse relaxation rate increase may be a specific measure of tissue iron stores. Magn Reson Med (1993) 1.37

Longer and shorter forms of Sendai virus C proteins play different roles in modulating the cellular antiviral response. J Virol (2001) 1.32

The clinical diagnosis of genital ulcer disease in men in the tropics. Sex Transm Dis (1984) 1.31

MRI evaluation of brain iron in earlier- and later-onset Parkinson's disease and normal subjects. Magn Reson Imaging (1999) 1.31

On the domain structure and the polymerization state of the sendai virus P protein. Virology (2000) 1.29

Reliability of in vivo volume measures of hippocampus and other brain structures using MRI. Magn Reson Imaging (1993) 1.27

The various Sendai virus C proteins are not functionally equivalent and exert both positive and negative effects on viral RNA accumulation during the course of infection. J Virol (1998) 1.27

Phylogenetic relationships of world populations of Bemisia tabaci (Gennadius) using ribosomal ITS1. Mol Phylogenet Evol (2000) 1.27

Mapping of monoclonal antibodies to the Sendai virus P protein and the location of its phosphates. J Virol (1988) 1.25

Hormonal changes in the postpartum and implications for postpartum depression. Psychosomatics (1998) 1.25

The parainfluenza virus type 1 P/C gene uses a very efficient GUG codon to start its C' protein. J Virol (1992) 1.25

Validation of the prospective NIMH-Life-Chart Method (NIMH-LCM-p) for longitudinal assessment of bipolar illness. Psychol Med (2000) 1.24

Costs and benefits of two doses of fluphenazine. Arch Gen Psychiatry (1984) 1.22

In vivo MR evaluation of age-related increases in brain iron. AJNR Am J Neuroradiol (1994) 1.21

Abstinence from cocaine reduces high-risk responses on a gambling task. Neuropsychopharmacology (2000) 1.20

Declarative and procedural memory in bipolar disorder. Biol Psychiatry (1999) 1.18

Sendai virus genome synthesis and assembly are coupled: a possible mechanism to promote viral RNA polymerase processivity. J Gen Virol (2001) 1.17

Alcohol increases cigarette smoking: a laboratory demonstration. Addict Behav (1985) 1.17

Backward masking in unmedicated schizophrenic patients in psychotic remission: possible reflection of aberrant cortical oscillation. Am J Psychiatry (1999) 1.17

Immigrant families coping with schizophrenia. Behavioral family intervention v. case management with a low-income Spanish-speaking population. Br J Psychiatry (1995) 1.17

Mutism: review, differential diagnosis, and report of 22 cases. Am J Psychiatry (1986) 1.16

A controlled dose comparison of haloperidol in newly admitted schizophrenic patients. Arch Gen Psychiatry (1990) 1.15

The mitochondrial rhomboid protease PSARL is a new candidate gene for type 2 diabetes. Diabetologia (2005) 1.12

A program for relapse prevention in schizophrenia: a controlled study. Arch Gen Psychiatry (2000) 1.12

Relapse of depression during pregnancy following antidepressant discontinuation: a preliminary prospective study. Arch Womens Ment Health (2004) 1.11

The Stanley Foundation Bipolar Treatment Outcome Network. I. Longitudinal methodology. J Affect Disord (2001) 1.11

Enabling the diagnosis of occult psychiatric illness in the emergency department: a randomized, controlled trial of the computerized, self-administered PRIME-MD diagnostic system. Ann Emerg Med (2001) 1.10

The vulnerability/stress model of schizophrenic relapse: a longitudinal study. Acta Psychiatr Scand Suppl (1994) 1.09

Gender and bipolar illness. J Clin Psychiatry (2000) 1.09

Expressed emotion and schizophrenic outcome among Mexican-American families. J Nerv Ment Dis (1987) 1.08

Haemophilus parasuis septicaemia in pigs. Aust Vet J (1983) 1.08

Supraphysiological doses of levothyroxine alter regional cerebral metabolism and improve mood in bipolar depression. Mol Psychiatry (2005) 1.08

Monetary reinforcement of abstinence from cocaine among mentally ill patients with cocaine dependence. Psychiatr Serv (1997) 1.07

Magnetic resonance imaging evidence of "silent" cerebrovascular toxicity in cocaine dependence. Biol Psychiatry (1999) 1.07

Relationship between blood pressure and subcortical lesions in healthy elderly people. Stroke (1998) 1.06

NLRX1/NOD5 deficiency does not affect MAVS signalling. Cell Death Differ (2011) 1.05

Comparison of efficacy of social skills training for deficit and nondeficit negative symptoms in schizophrenia. Am J Psychiatry (1997) 1.05

Low- and conventional-dose maintenance therapy with fluphenazine decanoate. Two-year outcome. Arch Gen Psychiatry (1987) 1.05